§ Mr. Gareth WardellTo ask the Secretary of State for Social Services when the conclusions of Dr. Warlow's study on the use of aspirin to prevent stroke and myocardial infarction are expected.
Mr. JacksonI have been asked to reply.
632W
Numbers of patients awaiting treatment for Opthalmology by District Health Authority and Special Health Authority as at 31 March 1987 Total cases Urgent Cases Non-urgent Cases All On list more than one month All On list more than one year Northern RHA Hartlepool 0 0 0 0 0 North Tees 0 0 0 0 0 South Tees 612 23 12 589 188 East Cumbria 58 0 0 58 0 South Cumbria 77 0 0 77 1 West Cumbria 146 0 0 146 0 Darlington 348 0 0 348 1 Durham 90 0 0 90 0 North West Durham 0 0 0 0 0 South West Durham 0 0 0 0 0 Northumberland 0 0 0 0 0 Gateshead 0 0 0 0 0 Newcastle 1,486 103 11 1,383 192 North Tyneside 0 0 0 0 0 South Tyneside 0 0 0 0 0 Sunderland 918 6 0 912 61 Yorkshire RHA Hull 375 0 0 375 21 East Yorkshire 0 0 0 0 0 Grimsby 187 0 0 187 4 Scunthorpe 488 0 0 488 210 Northallerton 0 0 0 0 0 York 531 4 0 527 61 Scarborough 399 1 0 398 23 Harrogate 157 3 0 154 8 Bradford 705 5 4 700 6 Airedale 0 0 0 0 0 Calderdale 96 2 0 94 0 I understand from the Medical Research Council that the preliminary results of Professor Warlow's United Kingdom transient ischaemic attack aspirin trial, on the prevention of stroke and myocardial infarction, were published in the British Medical Journal on Friday 29 January 1988.